Improving meningococcal MenACWY and 4CMenB/meningococcal group B vaccine‐related health literacy in patients: Importance of readability of pharmaceutical Patient Leaflets

Author(s):  
Orlaith C. Brennan ◽  
John E. Moore ◽  
Thomas W. Nutt ◽  
Peter JA Moore ◽  
Beverley C. Millar
1988 ◽  
pp. 147-152
Author(s):  
M. R. Lifely ◽  
U. T. Nowicka ◽  
E. Krambovitis ◽  
J. Esdaile

1997 ◽  
Vol 17 (3) ◽  
pp. 139-148 ◽  
Author(s):  
Eileene M. Rouppe van der Voort ◽  
Betsy Kuipers ◽  
Humphrey F. Brugghe ◽  
Leontine M.A. Unen ◽  
Hans A.M. Timmermans ◽  
...  

2019 ◽  
Vol Volume 12 ◽  
pp. 3169-3188 ◽  
Author(s):  
Irene Rivero-Calle ◽  
Peter Francis Raguindin ◽  
Jose Gómez-Rial ◽  
Carmen Rodriguez-Tenreiro ◽  
Federico Martinón-Torres

Eye ◽  
2005 ◽  
Vol 19 (5) ◽  
pp. 606-608 ◽  
Author(s):  
D Rathod ◽  
J D Heath
Keyword(s):  

2009 ◽  
Vol 16 (11) ◽  
pp. 1693-1695 ◽  
Author(s):  
George F. Santos ◽  
Marzia Giuliani ◽  
Laura Santini ◽  
Jeanette Adu-Bobie ◽  
Mariagrazia Pizza ◽  
...  

ABSTRACT The induction of resistance by immune selective pressure to bactericidal antibodies from humans immunized with Novartis recombinant meningococcal group B vaccines was assessed. Serum bactericidal antibody titers against selected bacteria were within assay variability through a selection event frequency of 1 in 10−5. No change in antigen expression was observed by Western blotting.


Sign in / Sign up

Export Citation Format

Share Document